First decade (1950-1960) of studies and trials with the polio vaccine

Biologicals

Volumn 34, Issue 2, 2006, Pages 81-86

  Koprowski, Hilary ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Mass vaccination trials; OPV early development; OPV first human trial

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; CLINICAL TRIAL; DRUG SAFETY; GEOGRAPHIC DISTRIBUTION; HISTORY OF MEDICINE; HUMAN; IMMUNE RESPONSE; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; HUMANS; INFANT; MASS IMMUNIZATION; POLIOVIRUS VACCINES;

POLIOVIRUS;

EID: 33646780217     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.03.009     Document Type: Article

References (55)

1. Oshinsky D.M. Polio - an American story (2005), Oxford University Press
2. Armstrong C. Experimental transmission of poliomyelitis to eastern cotton rat, Sigmodon hispidus. Health Rep 54 (Sept. 22, 1939) 1719-1721
3. Koprowski H., Jervis G.A., and Norton T.W. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg 55 (1952) 108-126
4. Koprowski H. Proceedings of a round table conference on immunization of poliomyelitis (March 1951), National Foundation for Infantile Paralysis, Hershey, PA (Unpublished)
5. Salk J.E., Lewis L.J., Bennett B.L., and Youngner J.S. Immunization of monkeys with poliomyelitis viruses grown in cultures of monkey testicular tissue. Fed Proc 11 (1952) 480
6. Koprowski H., Jervis G.A., Norton T.W., and Nelsen D.J. Further studies on oral administration of living poliomyelitis virus to human subjects. Proc Soc Exp Biol Med 82 (1953) 277-280
7. Salk J.E. Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress. JAMA 151 13 (1953) 1081-1098
8. Li C.P., and Schaeffer M. Adaptation of type 1 poliomyelitis virus to mice. Proc Soc Exp Biol Med 82 (1953) 477-481
9. Koprowski H., Jervis G.A., and Norton T.W. Oral administration of poliomyelitis virus to man and ape. A comparative study. Proc Natl Acad Sci U S A 40 (1954) 36-39
10. Koprowski H., Jervis G.A., and Norton T.W. Administration of an attenuated type l poliomyelitis virus to human subjects. Proc Soc Exp Biol Med 86 (1954) 244-247
11. Koprowski H., Jervis G.A., and Norton T.W. Persistence of neutralizing antibodies in human subjects three years after an oral administration of a rodent-adapted strain of poliomyelitis virus. Pediatrics 13 (1954) 203-205
12. Böttiger M., Gard S., and Lagercrantz R. Vaccination with attenuated type 1 poliovirus, the Chat strain. I. A study of 20 families. Acta Paediatr Scand 55 (1966) 405-415
13. Böttiger M., Gard S., and Zetterberg B. Vaccination with attenuated type 1 poliovirus, the Chat strain. II. Transmission of virus in relation to age. Acta Paediatr Scand 55 (1966) 416-421
14. Böttiger M., Böttiger E., and Zetterberg B. Vaccination with attenuated type 1 poliovirus, the Chat strain. III. Antibody response and spread of virus in schoolchildren. Acta Paediatr Scand 55 (1966) 422-431
15. Böttiger M., and Lagercrantz R. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families. J Pediatr 75 (1969) 30-38
16. Sabin A.B. Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. Ann N Y Acad Sci 61 (1955) 1050-1056
17. Sabin A.B. Behavior of chimpanzee-avirulent poliomyelitis viruses in experimentally infected human volunteers. Transact Assoc Am Physicians LXVIII (1955) 64-72
18. Salk J.E., Krech U., Youngner J.S., Bennett M.B.L., Lewis L.J., and Bazeley P.L. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am J Public Health 44 (1954) 563-570
19. Offit P.A. The cutter incident (2005), Yale University Press, New Haven and London
20. Courtois G., Flack A., Jervis G.A., Koprowski H., and Ninane G. Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi [in Spanish: Bol. Of. Sanit. Panam., 45: 93-98]. BMJ 2 5090 (1958) 187-190
21. Plotkin S.A., Jervis G., Norton T.W., Stokes Jr. J., and Koprowski H. Persistence of antibodies after vaccination with living attenuated poliovirus. JAMA 170 (1959) 8-12
22. Plotkin S.A., Koprowski H., and Stokes Jr. J. Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics 23 (1959) 1041-1062
23. Lebrun A., Cerf J., Gelfand H.M., Courtois G., and Koprowski H. Preliminary report on mass vaccination with live attenuated poliomyelitis virus in Leopoldville, Belgian Congo. First International Conference on Live Poliovirus Vaccines, June 22-26 (1959), Pan American Sanitary Bureau, Washington, D.C. 410-418
24. Plotkin S., and Koprowski H. Epidemiological studies of the safety and efficacy of vaccination with the CHAT strain of attenuated poliovirus in Leopoldville, Belgian Congo. First International Conference on Life Poliovirus Vaccines June 22-26 (1959), Pan American Sanitary Bureau, Washington, D.C. 419-436
25. Plotkin S.A., Lebrun A., and Koprowski H. Vaccination with the Congo. II: Studies of safety and efficacy of the vaccination. Bull WHO 22 (1959) 355-374
26. Salk J.E. Poliomyelitis vaccination in the fall of 1956. Am J Public Health 47 (1957) 1-18
27. Salk J.E. How many injections of poliomyelitis vaccine for effective and durable immunity. JAMA 167 1 (1958) 1-7
28. Salk J.E. Vaccination against poliomyelitis: an ounce of prevention. J R Soc Health 79 (1959) 310-322
29. Przesmycki F., Dobrowolska H., Georgiades J., Olakowski T., Stanczyk R., and Naruszewicz D. Report on field trials with live attenuated poliomyelitis vaccine of Koprowski in Poland. Am J Hyg 71 (1960) 275-284
30. Plotkin S.A. Recent results of mass immunization against poliomyelitis with Koprowski strains of attenuated live poliovirus. Am J Public Health 52 (1962) 946-960
31. Ikic D. Our experience with live, oral poliomyelitis vaccine Koprowski, type 1, 2, and 3. Radovi Immunoloskog Zavoda-Zagreb ViVI (1966) 139-141
32. Koprowski H. Zur Geschichte der Poliomyelitis-impfung mit lebenden viren. Schweiz Med Wochenschr 89 (1959) 1323
33. Sabin A.B. Present status of attenuated live virus poliomyelitis vaccine. Bull N Y Acad Med 33 1 (1957) 17-39
34. Sabin A.B. Status of field trials with an orally administered, live attenuated poliovirus vaccine. JAMA 171 (Oct 17 1959) 863-868
35. Pagano J.S., Plotkin S.A., Cornely D., and Koprowski H. Experimental infection with chat attenuated poliovirus in premature infants. Live poliovirus vaccines: papers presented and discussions held at second international conference on live poliovirus vaccines (1960), Pam American Health Org, Washington, D.C. 277-283 Scientific Publication. No. 50
36. Pagano J.S., Plotkin S.A., and Koprowski H. Variation in response in early life to vaccination with living attenuated poliovirus and lack of immunologic tolerance. Lancet 1 June 4 (1960) 1224-1226
37. Plotkin S.A., Koprowski H., Richardson S., and Stokes J. Vaccination of families against poliomyelitis by feeding and by contact spread of living attenuated virus: including studies of virus properties after human intestinal passage. Acta Paediatr 49 (1960) 551-571
38. Salk J.E., Younger J.S., Lewis L.J., and Bennett B.L. Immunologic classification of poliomyelitis viruses. IV. Results of typing by neutralization of prototype viruses with antiserum produced by vaccination monkeys with unknown strain and adjuvant. Am J Hyg 54 2 (September 1951) 255-267
39. Koprowski H., Jervis G.A., Norton T.W., and Nelsen D.J. Further studies on oral administration of living poliomyelitis virus on human subjects. Proc Soc Exp Biol Med 82 (1953) 277-280
40. Sabin A.B. Present status and future possibilities of a vaccine for the control of poliomyelitis. AMA Am J Dis Child 86 3 (September 1953) 301-310
41. Koprowski H., Jervis G.A., and Norton T.W. Administration of an attenuated type 1 poliomyelitis virus to human subjects. Proc Soc Exp Biol Med 86 (1954) 244-247
42. Sabin A.B., Hennessen W.A., and Warren J. Ultrafiltration and electron microscopy of three types of poliomyelitis virus propagated in tissue culture. Proc Soc Exp Biol Med 85 2 (1954) 359-363
43. Sabin A.B., Hennessen W.A., and Winsser J. Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types. J Exp Med July 99 6 (1954) 551-576
44. Koprowski H. Immunization of a man with living poliomyelitis virus. WHO Monograph Series 26 (1955) 335-356
45. Salk J.E., Lewis, Benett B.L., Ward E.N., Krech U., Younger J.S., et al. Antigenic activity of poliomyelitis vaccines undergoing field test. Am J Public Health 45 2 (Feb 1955) 151-162
46. Koprowski H., Norton T.W., Jervis G.A., Stokes Jr. J., McGee E.L., and Nelsen D.J. Immunization of children by feeding of living attenuated type 1 and type 2 poliomyelitis virus and the intramuscular injection of immune serum globulin. Am J Med Sci 232 4 (1956) 378-388
47. Koprowski H., Norton T.W., Hummeler K., Stokes Jr. J., Hunt Jr. A.D., Flack A., et al. Immunization of infants with living attenuated poliomyelitis virus. Laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies. JAMA 162 (1956) 1281-1288
48. Koprowski H., Norton T.W., Jervis G.A., Nelson T.L., Chadwick D.L., Nelsen D.J., et al. Clinical investigations of attenuated strains of poliomyelitis virus: use as a method of immunization of children living with the virus. JAMA 160 (1956) 954-966
49. Sabin A.B. Pathogensis of poliomyelitis; reappraisal in the light of new data. Science 123 3209 (June 29 1956) 1151-1157
50. Sabin A.B. Antipoliomyelitic vaccine; report prepared especially for the 7th Argentine Pediatric Conference. Dia Medico 28 31 (May 14 1956) 778-780
51. Sabin A.B. Present status of attenuated live-virus poliomyelitis vaccine. JAMA 162 18 (Dec 29, 1956) 1589-1596
52. Younger J.S., and Salk J.E. Antibody titer for seven different type 1 strains of poliomyelitis virus in children vaccinated with the Mahoney strain. Am J Hyg 63 2 (1956 March) 198-203
53. Ikic D. Speculation on tissue culture systems coming into consideration for the preparation of viral vaccines. What do we risk by using HDCS? Proc. Symp. The characterization and uses of human diploid cell strains. Opatija; 1963. p. 357-361.
54. Sabin A.B. Present position of immunization against poliomyelitis with live virus vaccines. BMJ 15 5123 (Mar 14 1959) 663-680
55. Pagano J.S., Plotkin S.A., Janowsky C.C., Richardson S., and Koprowski H. Routine immunization with oral attenuated poliovirus. A study of 850 children in an American city. JAMA 73 (1960) 1883-1889